ZBP1 and COVID-19: However, Zbp1–/– mice show reduced PANoptosis and mortality following IFN-β administration compared with WT mice19, suggesting that ZBP1-mediated PANoptosis impedes the therapeutic efficacy of IFN-β in COVID-19.